Lataa...
IMMU-20. CHARACTERIZING THE IMMUNE LANDSCAPE OF PD-1/PD-L1 IN BRAIN TUMOR IMMUNE CELL POPULATION USING CyTOF MASS CyTOMETRY
INTRODUCTION: Immunotherapy may be a viable and efficacious treatment strategy for glioblastoma and other brain tumors. However, the negative co-stimulatory molecule PD-1 and its ligand PD-L1, which contributes to T cell inhibition in the tumor context, may limit effective anti-tumor immune response...
Tallennettuna:
| Julkaisussa: | Neuro Oncol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693003/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.478 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|